Rocket pharmaceuticals is making a sequel
Rocket Pharmaceuticals is planning to make a sequel to its original rocket pharmaceuticals business, which launched in 2011.
The company announced Tuesday that it has entered into a joint venture with US-based drug maker Serono.
Rocket Pharmaceuticals was founded in 2014 by Robert Hurd, who previously worked at Merck, where he also worked as vice president of manufacturing.
The business, with a headquarters in San Diego, was able to get its first product, the Nexium capsule, off the ground with a small team.
The Nexium capsules are manufactured by Serono and sold to patients via a generic generic drug distribution network called Medpag.
The company’s first product was the EpiPen, which is manufactured by Johnson & Johnson.
The EpiPens were designed to be worn around the neck and have the same functionality as a pen.
Rocket Pharmaceutical was able get a patent on the Epipen in 2018.
The EpiPad is also made by Serano.
It was first launched in the United States in 2011 and has since been sold in other countries.
The device is manufactured in China by Shire Pharmaceuticals.
Serono has a licensing deal with the company, and it has a long-term relationship with Rocket.